Procyon Diagnostics
PrivateLast Round
Pre Seed
Oct 22, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Procyon Diagnostics operates in Healthcare & Life Sciences and is based in Skipton. Its latest recorded funding round was a Pre Seed round in October 2025.
Procyon Diagnostics is a biotechnology company that develops non-invasive diagnostic tests for early cancer detection using biomarker technology and machine learning.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Procyon Diagnostics Comparables
Compare Procyon Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Xgenera | 83% | |
| Immunovia AB (publ) | 78% | |
| Mursla Bio | 77% |
For institutional investors. Book with your work email.
Procyon Diagnostics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 22, 2025
Led by Queen Mary University of London with participation from Source BioScience.
For institutional investors. Book with your work email.
Procyon Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Procyon Diagnostics's valuation, stock price, and market status.
Is Procyon Diagnostics a public or private company?
Procyon Diagnostics is a private company.
What is the current stock price of Procyon Diagnostics?
Procyon Diagnostics is a private company, so its shares have no public market price. Caplight tracks Procyon Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Procyon Diagnostics worth (valuation)?
Valuation information for Procyon Diagnostics is not publicly available.
Can I buy Procyon Diagnostics stock?
Procyon Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Procyon Diagnostics's last funding round?
Procyon Diagnostics's most recent funding round was Pre Seed on October 22, 2025.
Who are the main investors in Procyon Diagnostics?
Investor information for Procyon Diagnostics is not publicly disclosed.
Will Procyon Diagnostics IPO soon?
No public IPO plans have been announced for Procyon Diagnostics.
How can I track Procyon Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades in Procyon Diagnostics's shares on secondary markets.